Immunobiologic Agents in Dermatology

Author(s): Neslihan sendur

Journal Name: Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
(Formerly Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents)

Volume 6 , Issue 3 , 2007

Become EABM
Become Reviewer


In recent years, the role of T cells, dentritic antigen presenting cells (APCs) and cytokine network in inflammatory dermatoses has been more completely understood. This in turn has enabled the completion of new potentials and goals in immunotherapy. As research in Immunodermatology increased, newly targeted treatments for immunodisfunction were also developed. These treatments were not only beneficial for the patient, but also created experimental tools for better understanding disease pathophysiology and for rethinking nosology. In Dermatology, especially psoriasis treatment, targeted biologic treatment methods have been developed. Immunobiologic treatments can be defined by the therapeutic agents produced by the organisms by using recombination biotechnology. This article will briefly discuss the general characteristics of immunobiologic agents.

Keywords: Biologic agents, dermatology

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2007
Page: [180 - 182]
Pages: 3
DOI: 10.2174/187152307781368238
Price: $65

Article Metrics

PDF: 6